Drug Type Small molecule drug |
Synonyms PV02076 |
Target |
Mechanism SLCO2A1 blockers(solute carrier organic anion transporter family member 2A1 blockers), Organic anion transporters inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Toxicity due to chemotherapy | Preclinical | US | 31 Oct 2017 | |
Nephrotoxicity | Discovery | US | - | |
Obesity | Discovery | US | - | |
Pulmonary Arterial Hypertension | Discovery | US | - |